Connett, Gary

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Heijerman, H. G. M., McKone, E. F., Downey, D. G., Van Braeckel, E., Rowe, S. M., Tullis, E., Mall, M. A., Welter, J. J., Ramsey, B. W., McKee, C. M., et al. (2019) · The Lancet

Cystic Fibrosis Research AdvancesPharmacogenetics and Drug Metabolism

Cited by 1,414

Dysfunctional breathing in children and adults with asthma

Connett, G. J., & Thomas, M. (2018) · Frontiers in Pediatrics

Asthma and respiratory diseasesRespiratory and Cough-Related Research

Cited by 58

Molecular Microbiological Characterization of Preterm Neonates at Risk of Bronchopulmonary Dysplasia

Payne, M. S., Goss, K. C. W., Connett, G. J., Kollamparambil, T., Legg, J. P., Thwaites, R., Ashton, M., Puddy, V., Peacock, J. L., & Bruce, K. D. (2010) · Pediatric Research

Neonatal Respiratory Health ResearchNeonatal and Maternal Infections

Cited by 58